High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma

被引：0
|
作者：
Quan, WDY
Taylor, WC
Ramirez, M
Vinogradov, M
Khan, N
Jackson, S
机构：
[1] Univ Texas, Med Branch, Galveston, TX 77550 USA
[2] E Carolina Univ, Sch Med, Greenville, NC USA
[3] Med Coll Ohio, Div Med Oncol & Hematol, Coll Med, Toledo, OH 43699 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2004年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [31] A PHASE-II STUDY OF HIGH-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH METASTATIC MELANOMA
    DUTCHER, JP
    GAYNOR, ER
    BOLDT, DH
    DOROSHOW, JH
    BAR, MH
    SZNOL, M
    MIER, J
    SPARANO, J
    FISHER, RI
    WEISS, G
    MARGOLIN, K
    ARONSON, FR
    HAWKINS, M
    ATKINS, M
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) : 641 - 648
  • [32] Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2
    Quan, WDY
    Khan, N
    Ramirez, M
    Taylor, WC
    Quan, F
    Vinogradov, M
    Walker, P
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2005, 20 (02) : 151 - 154
  • [33] Managing toxicities of high-dose interleukin-2
    Schwartz, RN
    Stover, L
    Dutcher, J
    ONCOLOGY-NEW YORK, 2002, 16 (11): : 11 - 20
  • [34] COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2
    THIJS, LG
    HACK, CE
    VANSCHIJNDEL, RJMS
    NUIJENS, JH
    WOLBINK, GJ
    EERENBERGBELMER, AJM
    VANDERVALL, H
    WAGSTAFF, J
    LANCET, 1989, 2 (8659): : 395 - 395
  • [35] CONTINUOUS INTRAVENOUS-INFUSION OF HIGH-DOSE RECOMBINANT INTERLEUKIN-2 FOR ADVANCED LYMPHOMAS - A PHASE-II STUDY
    LIM, SH
    WORMAN, CP
    CALLAGHAN, T
    JEWELL, A
    SMITH, MP
    GOLDSTONE, AH
    LEUKEMIA RESEARCH, 1991, 15 (06) : 435 - 440
  • [36] High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: The University of Chicago experience
    Shulman, KL
    Stadler, WM
    Vogelzang, NJ
    UROLOGY, 1996, 47 (02) : 194 - 197
  • [37] High-Dose Interleukin-2: Is It Still Indicated for Melanoma and RCC in an Era of Targeted Therapies?
    Amin, Asim
    White, Richard L., Jr.
    ONCOLOGY-NEW YORK, 2013, 27 (07): : 680 - 691
  • [38] INTERLEUKIN-2 AND HIGH-DOSE CISPLATIN IN PATIENTS WITH METASTATIC MELANOMA - A PILOT-STUDY
    DEMCHAK, PA
    MIER, JW
    ROBERT, NJ
    OBRIEN, K
    GOULD, JA
    ATKINS, MB
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (10) : 1821 - 1830
  • [39] Sequential administration of high-dose interleukin-2 and ipilimumab in patients with metastatic melanoma.
    Patel, Sapna Pradyuman
    Milton, Denai
    Milhem, Mohammed M.
    Flaherty, Lawrence E.
    Hallmeyer, Sigrun
    Feun, Lynn G.
    Hauke, Ralph J.
    Cranmer, Lee D.
    Daniels, Gregory A.
    Doolittle, Gary C.
    Taback, Bret
    Morse, Michael
    Lutzky, Jose
    Sharfman, William Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] The treatment of disseminated skin melanoma with high-dose recombinant interleukin-2 in combination with chemotherapy
    Streltsova, O.
    Baranau, Y.
    ANNALS OF ONCOLOGY, 2017, 28
12345